Overview
1. Emerging Infections
2. Global Health
3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics
5. Bioterrorism Preparedness
6. Surveillance for communicable diseases
7. Antimicrobial resistance
2. Global Health
3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics
5. Bioterrorism Preparedness
6. Surveillance for communicable diseases
7. Antimicrobial resistance
Current Duke Appointments & Affiliations
Wolfgang Joklik Distinguished Professor of Global Health
·
2023 - Present
Medicine, Infectious Diseases,
Medicine
Professor of Medicine
·
2014 - Present
Medicine, Infectious Diseases,
Medicine
Associate Director of Duke Center for Applied Genomics and Precision Medicine
·
2014 - Present
The Precision Medicine Program,
Medicine
Research Professor of Global Health
·
2011 - Present
Duke Global Health Institute,
University Institutes and Centers
Professor in Pathology
·
2014 - Present
Pathology,
Clinical Science Departments
Member of the Duke Human Vaccine Institute
·
2023 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Recent Scholarly Works
Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.
Journal article Lancet · September 12, 2026 BACKGROUND: There are currently no licensed vaccines for disease caused by Bundibugyo virus (BDBV). The recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein (rVSVĪG-ZEBOV-GP) vaccine has been widely deployed during Ebola virus disease outb ... Full text Link to item CiteInnate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.
Journal article Nat Med · July 2026 Controlled human influenza infection studies can uniquely interrogate the early immune factors associated with clinical outcome. In this study, 27 healthy volunteers with low strain-specific serum neutralizing antibody levels were challenged with influenza ... Full text Link to item CiteInfluenza coinfection inhibits control of mycobacterial infection in a human challenge model.
Journal article Nat Commun · June 11, 2026 Mycobacterium tuberculosis infection is a dynamic continuum. Clinical outcomes reflect complex host-pathogen interactions. Epidemiological and animal studies have suggested influenza coinfection as a risk factor for progression from contained infection to ... Full text Link to item CiteRecent Grants
Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2030Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2029View All Grants
Education
Duke University ·
1994
M.D.